Table 4.
Association with Helicobacter pylori infection and Esophageal cancer
|
Prevalence of H. pylori
|
Diagnostic tool of H. pylori
|
Study design
|
P
value
|
Rokkas et al[44] | EAC: 0.52 (95%CI: 0.37-0.73) | Serology and/or histology | Meta-analysis | EAC: P < 0.001 |
ESCC: 0.85 (95%CI: 0.55-1.33) | ESCC: P = 0.48 | |||
Islami et al[45] | EAC: 0.56 (95%CI: 0.46-0.68) | Serology and/or histology | Meta-analysis | NA |
ESCC: 1.10 (95%CI: 0.78-1.55) | ||||
Nie et al[46] | EAC: 0.57 (95%CI: 0.44-0.73) | Serology and/or histology; rapid urease test | Meta-analysis | NA |
ESCC:1.16 (95%CI: 0.8.-1.60) | ||||
Xie et al[47] | EAC: 0.59 (95%CI: 0.51-0.68) | Serology and/or histology; rapid urease test | Meta-analysis | NA |
ESCC: 0.97 (95%CI: 0.76-1.24) | ||||
ESCC in Eastern: 0.66 (95%CI: 0.43-0.89) |
CI: Confidence interval; H. pylori: Helicobacter pylori; EAC: Esophageal adenocarcinoma; ESCC: Esophageal squamous-cell carcinoma; NA: Not available.